CENTEK(SZ:000931) Shang Hai Zheng Quan Bao·2025-12-26 19:13Core Viewpoint - Beijing Zhongguancun Science and Technology Development (Holding) Co., Ltd. announced the withdrawal of the drug registration application for Acetaminophen and Oxycodone Tablets by its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. to further improve the application materials [1][2]. Group 1: Basic Information - The drug name is Acetaminophen and Oxycodone Tablets, with a registration number of CYHS2404364 and a notification number of 2025L00518 [1]. - The National Medical Products Administration (NMPA) issued a termination notice agreeing to withdraw the registration application based on the applicant's request [1]. Group 2: Reasons for Withdrawal and Future Plans - The decision to withdraw the application was made after careful consideration, with plans to resubmit the application after improving the relevant research [2]. Group 3: Impact on the Company - The project for Acetaminophen and Oxycodone Tablets has seen a total investment of 8.861 million yuan, with 5.5371 million yuan capitalized and 3.3239 million yuan expensed as of the announcement date [3]. - The withdrawal of the drug registration application will not impact the company's current financial status or operating performance [4].